SCHEMBL620055

SCHEMBL620055

Cc1ccc2[nH]c3c(c2c1)CN(C(=O)NSc1ccc(F)cc1)CCC3

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BAZ2B Q9UIF8 4/20 0.55
SMN1; SMN2 Q16637 3/20 0.52
LMNA P02545 1/20 0.52
PABPC1 P11940 1/20 0.52
ATM Q13315 1/20 0.52
NPC1 O15118 1/20 0.51
ALDH1A1 P00352 6/20 0.49
MAPT P10636 5/20 0.49
MEN1 O00255 5/20 0.49
KMT2A Q03164 5/20 0.49
KDM4E B2RXH2 2/20 0.49
ALOX15 P16050 1/20 0.49
TSHR P16473 1/20 0.49
HSD17B10 Q99714 1/20 0.49
KDR P35968 1/20 0.48
HPGD P15428 2/20 0.47
CYP1A2 P05177 1/20 0.47
POLB P06746 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL620056 0.78 MAPT (0.65) BAZ2BSMN1; SMN2LMNAPABPC1ATM
SCHEMBL621736 0.78 BAZ2B (0.59) BAZ2BSMN1; SMN2LMNAPABPC1ATM
SCHEMBL620034 0.76 BAZ2B (0.86) BAZ2BSMN1; SMN2LMNAALDH1A1MAPT
SCHEMBL620615 0.75 LMNA (0.87) BAZ2BSMN1; SMN2LMNAPABPC1ATM
SCHEMBL620479 0.74 BAZ2B (0.63) BAZ2BSMN1; SMN2LMNAPABPC1ATM
SCHEMBL10127719 0.74 LMNA (0.66) BAZ2BSMN1; SMN2LMNAPABPC1ATM
SCHEMBL13356184 0.73 LMNA (0.65) BAZ2BSMN1; SMN2LMNAPABPC1ATM
SCHEMBL12868355 0.72 BAZ2B (1.00) BAZ2BSMN1; SMN2LMNAPABPC1ATM
SCHEMBL3424575 0.72 BAZ2B (0.81) BAZ2BSMN1; SMN2LMNAPABPC1ATM
SCHEMBL10127727 0.71 BAZ2B (0.62) BAZ2BSMN1; SMN2LMNAPABPC1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120040965-A1 SUBSTITUTED AZEPINO[4,3-B]INDOLES, PHARMACOLOGICAL COMPOSITION AND A METHOD FOR THE PRODUCTION AND USE THEREOF BORISOVICH FROLOV YEVGENIY (RU) 2012-02-16 US disclosed
EP-2062895-A1 SUBSTITUTED AZEPINO[4,3-B]INDOLES, PHARMACOLOGICAL COMPOSITION AND A METHOD FOR THE PRODUCTION AND USE THEREOF Alla Chem, LLC. (US) 2009-05-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120040965-A1 SUBSTITUTED AZEPINO[4,3-B]INDOLES, PHARMACOLOGICAL COMPOSITION AND A METHOD FOR THE PRODUCTION AND USE THEREOF ABCG2, HTR3C, AADAC BAZ2B 428/4885SMN1; SMN2 3920/4885LMNA 2065/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.